French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open lower
09/14/2026 09:18 AM - Politics
Vice president returns home after Italian visit
09/14/2026 08:59 AM - Society
Court approves detention of man who held intern at knifepoint at airport
09/13/2026 10:13 PM - Business
Mandarin Airlines A321neo makes domestic debut on domestic route
09/13/2026 07:31 PM - Sports
Dwight Howard headlines New Taipei Kings charity event
09/13/2026 06:07 PM